NSE filing, NSE: SYRMA. Summary written from the filing by ALFA Finder's alert engine.
Syrma SGS Technology Ltd: key numbers
- Share price
- ₹1,625.30
- Market cap
- ₹31,281 Cr
- Revenue (annual)
- ₹4,819 Cr
- Net profit (annual)
- ₹317.8 Cr
- P/E (TTM)
- 85.0×Sector 41.2×
- Promoter holding
- 41.63%-0.65% QoQ
- FII holding
- 9.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syrma SGS Technology Ltd
All →Syrma SGS Technology Employee Stock Options
Syrma SGS granted 4,42,486 stock options under its ESOP Plan 2023, exercisable into equity shares of Rs. 10 each. Vesting is staggered over five years at market price.
Syrma SGS Technology Q2 FY27 Results: Net Profit ₹124.2 Cr, Up 87.3% YoY
Syrma SGS Technology Ltd reported revenue from operations of ₹1,990 Cr (+73.6% YoY) and net profit of ₹124.2 Cr (+87.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹124.2 Cr · +87.3% YoY
Syrma SGS Technology Earnings Call Transcript: Key Takeaways
Syrma delivered an exceptionally strong Q1 with 67% revenue growth and 112% PAT growth, driven by export buoyancy and ODM traction.
- Call
- Guides 35% growth
Syrma SGS Technology Board Meeting Date
Syrma SGS Technology has scheduled a board meeting for October 30, 2026, to consider and approve the company's standalone and consolidated financial results.
Syrma SGS Technology Other Announcement
Syrma SGS Technology Limited has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per Regulation 31 of SEBI LODR.
Syrma SGS Technology Capital Structure Change
Franklin Templeton Mutual Fund sold 110,190 equity shares of Syrma SGS Technology Ltd via open market. The transaction reduced its holding from 3.069% to 3.012%.
Other results update announcements
All →Narayana Hrudayalaya Results Update
Narayana Hrudayalaya reported Q2 FY27 consolidated revenue of Rs 28,440 Mn, up 73% YoY. PAT rose 16.6% to Rs 3,012 Mn, with the UK acquisition boosting revenue.
Corona Remedies Results Update
Corona Remedies released unaudited Q2 and H1 FY27 results highlights via press release. Revenue grew 22% year on year, with EBITDA and PAT also rising.
Acme Universal Safezone 9 Results Update
Acme Universal Safezone 9 reported H1FY27 revenue up 16.09% to ₹119.93 crore. EBITDA rose 54.62% and PAT turned to ₹7.02 crore profit.
Radiowalla Network Results Update
Radiowalla Network reported H1 FY27 revenue of ₹107.93 million, up 7% year-on-year. EBITDA rose to ₹8.16 million, with an 8% margin.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Advait Energy Transitions Results Update
Advait Energy reported Q2 FY27 consolidated revenue of ₹220.9 crore, up 40.8%, and PAT of ₹19.18 crore, up 88.5%. Its order book reached ₹1,574.8 crore.
- Order book
- ₹1,575 Cr